Why Is Fenofibrate So Hard to Find? [Explained for 2026]

You called three pharmacies. You drove across town. And still no fenofibrate. If this sounds familiar, you are not alone. Even though fenofibrate is a widely available generic medication with no active FDA shortage, many patients still run into roadblocks filling their prescription. Here is what is really going on — and what you can do about it.

Is There a Fenofibrate Shortage in 2026?

As of 2026, there is no active FDA-declared national shortage of fenofibrate. The good news: fenofibrate has been generic for many years and is manufactured by multiple companies. That means supply at the national level is generally stable.

However, individual pharmacies often run out of specific strengths or formulations. This is a localized supply-and-demand issue rather than a manufacturing crisis — but for you and your prescription, the practical result can feel the same.

Why Does Fenofibrate Run Out at Individual Pharmacies?

Several factors drive localized stock-outs of fenofibrate, even when there is no national shortage:

• Multiple formulations and strengths. Fenofibrate comes in tablets and capsules in at least ten different strengths — 43 mg, 48 mg, 54 mg, 120 mg, 130 mg, 134 mg, 145 mg, 150 mg, 160 mg, and 200 mg. A pharmacy may have 145 mg tablets in stock but be out of 160 mg tablets. Your specific dose matters.
• Generic manufacturer variability. Each pharmacy contracts with specific generic manufacturers. If your pharmacy's preferred supplier has a backlog or production delay, that location may be out even while other pharmacies nearby have plenty.
• Brand vs. generic availability. Brand-name versions like Tricor, Lipofen, and Antara are harder to find than generic fenofibrate. If your prescription specifies a brand name, your options shrink considerably.
• Smaller pharmacies order less. Independent pharmacies and smaller chains often carry smaller inventories and may not reorder until they run out completely. Large chain pharmacies and mail-order pharmacies tend to have more consistent stock.
• Cardiovascular labeling updates drawing attention. In late 2025, the FDA updated fenofibrate's labeling to clarify its lack of proven cardiovascular benefit. This generated media coverage and may have prompted some patients to fill prescriptions sooner than expected, creating temporary local demand spikes.

Which Fenofibrate Formulations Are Hardest to Find?

Based on pricing data and availability reports, the most commonly available formulations are generic fenofibrate 145 mg and 160 mg tablets. These are the workhorse doses for most patients with mixed dyslipidemia.

Formulations that may be harder to locate include:

• Brand-name Tricor (145 mg) — largely discontinued at retail; most patients are switched to generic
• Lipofen capsules (150 mg) — pricing data shows retail prices above $400 for 90 capsules, suggesting limited generic competition at this strength
• Fenoglide tablets (40 mg and 120 mg) — less common strengths with fewer manufacturers

Does the 2025 FDA Labeling Change Affect Availability?

In October 2025, the FDA updated fenofibrate's prescribing information to state clearly that the drug did not reduce cardiovascular disease morbidity or mortality in two large clinical trials — the FIELD trial (2005) and the ACCORD Lipid trial (2010). The updated label also narrowed the indication to reducing elevated LDL-C in adults with primary hyperlipidemia when recommended LDL-lowering therapies cannot be used.

This does NOT mean fenofibrate was taken off the market. It remains FDA-approved for reducing triglycerides and LDL cholesterol, and it is still widely prescribed. The labeling change primarily affects how doctors communicate the cardiovascular benefit (or lack thereof) to patients. It does not impact availability.

What Should You Do If Your Pharmacy Is Out of Fenofibrate?

Here are practical steps to take right now:

1. Ask your pharmacist about a different strength or formulation. Your doctor may be able to prescribe an equivalent dose in a different form that is currently in stock.
2. Check multiple pharmacies. Stock varies dramatically from one location to another, even within the same chain. A CVS two miles away may have plenty while your usual location is empty.
3. Consider mail-order pharmacy. Mail-order pharmacies through your insurance plan often have better and more consistent stock of common generics like fenofibrate.
4. Use medfinder to locate stock near you. medfinder calls pharmacies near you to find out which ones can fill your prescription — saving you the legwork.
5. Talk to your doctor about alternatives. If fenofibrate remains unavailable, gemfibrozil (Lopid) and prescription omega-3 fatty acids (Vascepa, Lovaza) are commonly used alternatives for hypertriglyceridemia. See our full guide to alternatives to fenofibrate for more information.

How medfinder Helps You Find Fenofibrate in Stock

Rather than spending an afternoon calling pharmacies yourself, medfinder does it for you. You provide your medication, dosage, and zip code, and medfinder calls pharmacies in your area to find out which ones have your prescription ready to fill. Results are texted directly to you — no hold music, no runaround.

This is especially useful with fenofibrate because availability varies so much by pharmacy location and formulation. Instead of guessing which pharmacy has 160 mg tablets in stock, medfinder verifies it for you.

Bottom Line

Fenofibrate is not in a national shortage in 2026 — but localized stock-outs are real and frustrating. The combination of many different formulations, manufacturer-specific contracts at each pharmacy, and brand-versus-generic differences means availability varies widely. Your best strategy is to check multiple pharmacies, consider mail-order, and use tools like medfinder to track down stock fast. For a deeper dive into finding fenofibrate near you, see our guide on how to find fenofibrate in stock.